A new Progress in Polymer Science review explores the versatile family of polyphenol-functionalised polymers, and how to harness these structures for drug delivery and smart tech research. University of Melbourne, Gyeongsang National Uni ➡️ https://ow.ly/2nkR50ZxfRH #PolymerScience

Congratulations to Dr Shiyao Li on being awarded a 2026 Harold Mitchell Travel Fellowship! This award gives emerging researchers the opportunity to attend in-person conferences and to visit renowned laboratories overseas. ➡️ https://ow.ly/MuAn50ZuSLh #CancerResearch #Fellowship #nanomedicine

ONJCRI and La Trobe University (LaTrobeUni) researchers have found that even a modest reduction in BECLIN1 leads to a significant increase in gut inflammation, resulting in greater susceptibility to disease and complications over time ➡️ https://ow.ly/nP0o50ZmgwB #beclin1 #bowelcancer #IBD #autophagy

Congratulations to our students who participated in the annual 3-Minute Thesis competition and thank you to the judges. 🥇 Biswadeep Sen, who will go on to represent our School at the University round 🥈 Runner-Up: Kurtis Green 🏅 People’s Choice: Olympia Nteris La Trobe University (LaTrobeUni) #3MT

New review paper by the NGTL published in Advanced Drug Delivery Reviews. • Brings together current knowledge on anti-PEG Abs • Discusses ways to reduce immune system interference • Highlights that anti-PEG Abs could be leveraged to develop new cancer therapies ➡️ https://ow.ly/hNYc50ZiZoP

🎉 Congratulations to Dr Juliani for being awarded the 2025 Student Prize! Dr Juliani received the award in recognition of her significant research achievements during her studies. ➡️ Read more about Juliani’s research journey: https://ow.ly/EYkY50Ze3Mn

🧬 ~30% of colorectal tumours lose MHC-I, the "ID tag" immune cells use to spot cancer. ONJCRI PhD candidate Andrew Li shows γδ T cells are significantly increased in these "invisible" tumours, opening the door for new immunotherapies. Open access: https://ow.ly/EefF50Zc6WB #Cancer #TCells #MHC

Congratulations to Yi David Ju for receiving the Springer Nature Editorial Contribution Award in recognition of his important editorial contributions to the Journal of Materials Science. #SpringerNature #EditorialAward #Nanomedicine

New research led by Dr Elizabeth Goodall reveals a striking gap between clinical trial recruitment criteria and real-world cancer patients ➡️ Read the British Journal of Haematology paper: https://onlinelibrary.wiley.com/doi/10.1111/bjh.70550 #LymphomaResearch #CancerResearch #ClinicalTrials

A new review paper by ONJCRI researchers Anamika Saini and Dr Shiyao Li investigates how the biomolecular corona that forms on RNA-lipid nanoparticles shapes their cargo delivery behaviour. ➡️ ow.ly/mOhR50Z5rpA (ACS Nano @pubs.acs.org) #LipidNanoparticles #Nanomedicine

Global cancer care faces a 100 million worker shortfall by 2050, suggests new Commission report. With coordinated investment: 📌 170 million deaths prevented 📌 $120 trillion net economic benefit Prof Andrew Scott was a Commission co-author. Read more in The Lancet Oncology: tinyurl.com/ysa9zv37

We are delighted to share that our 2025 Annual Report is now published and available to read ➡️️ https://ow.ly/4nWW50Z4xVA #CancerResearch #AnnualReport

🎉 Congratulations to postdoctoral researcher Dr Pavitha Parathan for becoming the first-ever recipient of Pancare Foundation's Eliza Wilmot Scholarship. ➡️ Read more: https://ow.ly/zJ0150Z1rF2

🎉 Congratulations to PhD student Birhanu Ayelign for receiving an Abacus Dx 2026 Emerging Investigators Grant to advance his phage therapy research in gastric cancer. #gastriccancer #phagetherapy

Congratulations to Prof Eliza Hawkes, her team and collaborators who received a $1.9m Cancer Australia grant to activate the iLIMM lymphoma study. Objectives: • Advanced tumour and immune system mapping • Testing whether physical exercise could improve outcomes ➡️ https://ow.ly/a8KN50YVmKN #NHMRC

Results from ONJCRI’s MoST-CIRCUIT clinical trial suggest that combination immunotherapy with nivolumab and ipilimumab is a promising avenue for hard-to-treat gallbladder cancer patients. ➡️ https://ow.ly/RLX450YT3pI #ClinicalTrials #GallbladderCancer #BiliaryTractCancer #immunotherapy

Congratulations to Kaitlyn Kew on receiving a Tour de Cure PhD Scholarship 👏 Her research is on children with B-cell acute lymphoblastic leukaemia (B-ALL). With ~10% of patients experiencing relapse, this work could help drive more effective treatments. #CancerResearch #PhD #Leukaemia

Congratulations to our researchers who were awarded funding from Tour de Cure to pursue innovative and impactful cancer research projects. • Dr Bhupinder Pal • Dr Zhipeng Cao • Dr Rebekah Crake ➡️ Read more: https://ow.ly/HARX50YKLUi #CancerResearch #ResearchFunding

Congratulations to Tawany De Carvalho Gil, awarded a PhD Top-Up Scholarship from the Jreissati Pancreatic Cancer Centre! Her research uses antibody-based biomarkers as an early warning system for pancreatic cancer detection.

Prof Andrew Scott played a key role in the development of a new global agreement that will improve the standardisation of medical imaging data from clinical trials, developed by ARTnet, SNMMI CTN and EARL. ➡️ https://ow.ly/V0os50YIC9p #NCRIS20 #NCRISimpact

Australia's premier CRISPR conference is back! 🧬 Accelerate your research, and spend two days connecting with international and local experts on cutting-edge gene editing. March 24-25 | Melbourne Connect Register: crispr.org.au Register now ➡️ http://crispr.org.au #CRISPR #CDU2026 #CRISPRDownUnder

Researchers from ONJCRI, WEHI and Peter Mac have discovered that DNA barcoding can be used to track cancer cells in solid and liquid biopsies. In a world-first, the team were able to detect the DNA barcodes shed by the primary tumour in plasma samples. ➡️ https://ow.ly/fcK550Yc0WN

🌏 Last night we marked World Cancer Day with a public event at ONJCRI, co-hosted with La Trobe Institute for Molecular Science (LIMS). Our community explored cutting-edge cancer research and heard from an inspiring panel. Thank you to all who joined us! Read more: https://ow.ly/U6Hp50Y98im

🎉 Proud to share that Dr Andrew Guirguis has been awarded a Cancer Council Victoria fellowship to investigate how pre-leukaemic blood conditions progress to acute leukaemia, and how that progression could be stopped. ➡️ Read: https://ow.ly/6AiY50Y5Laf #CancerResearch #CCV #CRFV #BloodCancer

We are delighted to share that recruitment for our Phase II VADER trial for patients with advanced bowel cancer is now complete, at nine centres across Australia. ➡️ Learn more: https://ow.ly/jfI450Y0ZtS AGITG and GI Cancer Institute #CancerTrials #BowelCancer #ColorectalCancer

A feature in Nature explores how researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment. #medsky 🧪

Why cancer can come back years later — and how to stop it

Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

go.nature.com

ONJCRI is thrilled to announce that Prof Eliza Hawkes and Prof Hui Gan have received MRFF Clinical Trials Activity funding to lead new and impactful clinical trials for blood and brain cancer patients. ➡️ https://ow.ly/mEgi50XZUuX #ClinicalTrials #CancerTrials #Glioblastoma #Lymphoma #MRFF

‘The Beginning’ by Rebecca Brown, PhD student 💡 Discover our Science Meets Art masterpieces: https://sciencemeetsart.com.au/shop/ #ScienceMeetsArt #MicroscopyArt #BreastCancerResearch

🔬 Thank you for being on the journey with our team in 2025. We look forward to sharing our breakthroughs and impact stories with you in 2026. If you would like to stay up to date with our news, subscribe to our newsletter: https://www.onjcri.org.au/subscribe-to-our-newsletter/ #CancerResearch

‘The Second Brain in the Colon’ by Dr Pavitha Parathan, Postdoctoral Researcher  💡 Discover our Science Meets Art masterpieces: https://sciencemeetsart.com.au/shop/ #ScienceMeetsArt #MicroscopyArt #BowelCancer